Experience and Management of Cancer Screening-Related Anxiety in Fanconi Anemia
NCT ID: NCT06744283
Last Updated: 2025-12-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
20 participants
OBSERVATIONAL
2025-12-30
2026-01-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Fanconi anemia (FA) is a rare, inherited cancer syndrome. FA causes a range of physical issues. Children with FA may have abnormal features; these may include a small head and eyes and issues with their internal organs. Young adults have a much higher risk of cancer. To screen for these cancers, people with FA may need to pursue many visits with different doctors. This constant need for cancer screening may cause anxiety for people with FA.
Objective:
To learn more about anxiety related to cancer screenings in people with FA.
Eligibility:
Adults aged 18 years and older with FA. They must also be enrolled in FACSS. FACSS is a study that screens people with FA for cancer every year.
Design:
All data gathered for this study will occur during routine FACSS visits. No other visits are needed.
An observer will be in the room during participants FACSS visits. The observer and participant will have a polite introduction. After that, the observer will not interact with participants in any way.
The observer will note details about the participants, such as:
* Body language.
* Worries about screening.
* Comments that suggest anxiety or depression.
* Clinical environment, such as d(SqrRoot)(Copyright)cor and temperature.
* Accessibility issues. These can include lights and noises as well as ease of traveling around the clinic center.
* Evidence of social support, such as engaging in the FA community.
* Challenges they ve had in FACSS.
* Their motivation to participate in FACSS.
* Relationship dynamics among clinic staff, participants, and their care partners.
Data will also be collected from FACSS visit notes dating back to December 2024 and from participants medical records.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This study will explore the experience and management of screening related anxiety in Fanconi Anemia (FA) among participants in the Fanconi Anemia Cancer Screening Study (FACSS) protocol (NIH IRB #:001109). Knowledge generated from this study will improve understanding of the experience and management of cancer screening-related anxiety in the context of complex, rare disease, while providing much-needed information about the health experiences and challenges within the FA community.
Objectives:
To collect ethnographic observational field notes to explore the nature of cancer screening-related anxiety experienced by participants in the FACSS screening study at the NIH clinical center.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Participants with a diagnosis of Fanconi anemia
Participants enrolled in the Fanconi Anemia Cancer Screening Study (FACSS) protocol (NIH IRB #: 001109) who are 18 years of age or older are eligible for inclusion in this study.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
To be eligible, the following requirements must be met:
* Ability for the participant to speak, read, and/or write in English to understand and agree to a verbal consent.
* Participants must have a diagnosis of FA.
* Participants must be 18 years of age or older.
Exclusion Criteria
* Subjects who declined or opted out of allowing their data to be used for future research.
* Subjects who orally declined to have Dr. Emily Pearce shadow their clinical center visits.
* No other exclusionary criteria apply.
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sharon A Savage, M.D.
Role: PRINCIPAL_INVESTIGATOR
National Cancer Institute (NCI)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Cancer Institute (NCI)
Bethesda, Maryland, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Emily Pearce, M.P.H.
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
002289-C
Identifier Type: -
Identifier Source: secondary_id
10002289
Identifier Type: -
Identifier Source: org_study_id